Early Rehabilitation for Severe Acute Pancreatitis (ERN-SAP)
Effect of a Structured Early Rehabilitation Program on Long-Term Functional Recovery, Quality of Life, and Survival in Patients With Severe Acute Pancreatitis: A 5-Year Randomized Controlled Trial
1 other identifier
interventional
400
1 country
1
Brief Summary
This prospective, randomized controlled trial investigates the efficacy of a structured early rehabilitation nursing (ERN) program compared to usual care in patients with severe acute pancreatitis (SAP). Four hundred patients admitted to the intensive care unit (ICU) were randomized to either receive the ERN intervention or usual care. The study aims to evaluate the effects of ERN on ICU and hospital length of stay, systemic inflammation, physical function, long-term quality of life, and one-year survival.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 30, 2025
CompletedFirst Posted
Study publicly available on registry
August 7, 2025
CompletedAugust 7, 2025
July 1, 2025
5 years
July 30, 2025
August 6, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
ICU Length of Stay (LOS)
Defined as the time from ICU admission to discharge, measured in days.
From ICU admission to ICU discharge (assessed up to 90 days)
Hospital Length of Stay (LOS)
Defined as the total time from hospital admission to discharge, measured in days.
From hospital admission to hospital discharge (assessed up to 90 days)
Secondary Outcomes (8)
Change in C-reactive protein (CRP) level
Baseline, Day 7
Change in Interleukin-6 (IL-6) level
Baseline, Day 7
Muscle Strength
At ICU discharge (within 24 hours prior to transfer from ICU)
Change in Functional Independence
Baseline (at ICU admission), at hospital discharge, and at 3, 6, and 12 months post-discharge
Change in Quality of Life
Baseline (at ICU admission), at hospital discharge, and at 3, 6, and 12 months post-discharge
- +3 more secondary outcomes
Study Arms (2)
Experimental: Early Rehabilitation Nursing (ERN) Group
EXPERIMENTALIn addition to usual care, patients received a protocolized, multidisciplinary rehabilitation program initiated within 48 hours of ICU admission. The program consisted of progressive, goal-directed mobilization, respiratory therapy, and psychological support, delivered 7 days a week by trained nurses and physical therapists.
Active Comparator: Usual Care Group
ACTIVE COMPARATORPatients received standard ICU care for SAP, including hemodynamic monitoring, mechanical ventilation, fluid management, nutritional support, and pain control. Rehabilitation was not protocolized and was provided only at the discretion of the treating physician.
Interventions
A protocolized, phased program. Phase 1 (unconscious): passive range of motion and repositioning. Phase 2 (awake/stable): respiratory training (deep breathing, incentive spirometry), bed mobility (bridging, rolling), and progressive mobilization (sitting at edge of bed). Phase 3 (active): in-place stepping and supervised ambulation. Psychological support was provided throughout. Safety criteria were monitored continuously.
Standard ICU management for SAP as directed by the primary ICU team. Rehabilitation was discretionary, typically limited to passive range of motion exercises by bedside nurses if deemed necessary.
Eligibility Criteria
You may qualify if:
- Age 18 to 75 years.
- A diagnosis of SAP according to the 2012 revised Atlanta classification.
- Admission to the ICU within 72 hours of symptom onset.
- An anticipated ICU stay of more than 48 hours.
You may not qualify if:
- Pre-existing conditions precluding rehabilitation (e.g., severe neuromuscular disease, unstable spinal fractures).
- Acute myocardial infarction or unstable cardiac arrhythmia.
- Intracranial hypertension.
- Active gastrointestinal bleeding.
- Pregnancy.
- Patient or family refusal.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University
Wuhan, Hubei, 430000, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 30, 2025
First Posted
August 7, 2025
Study Start
June 1, 2019
Primary Completion
June 1, 2024
Study Completion
June 1, 2025
Last Updated
August 7, 2025
Record last verified: 2025-07